BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211102
DTEND;VALUE=DATE:20211105
DTSTAMP:20260515T223747
CREATED:20210823T081823Z
LAST-MODIFIED:20210823T081930Z
UID:31388-1635811200-1636070399@www.pharmajournalist.com
SUMMARY:Gastrointestinal Cancer Drug Development Summit
DESCRIPTION:The Gastrointestinal Cancer Drug Development Summit is the only biopharma-led conference dedicated to identifying and progressing therapeutic opportunities in targeted and immunotherapies\, ADCs\, and precision oncology to address the large unmet clinical need in GI cancers. \n**This meeting is free-to-attend for drug developers\, research institutions\, and not-for-profit organizations**. \nRegister free to attend here: https://ter.li/t83wdr    \nThis industry-dedicated meeting offers a comprehensive insight into developing optimal clinical programs for targeted\, immune\, and ADC therapies in these solid tumors. Join us and our 39+ expert speaker faculty as we navigate cancer heterogeneity and develop biomarker-driven enrichment strategies to direct better treatments to specific patient subsets and invest in rationale therapeutic combination approaches for this vastly unmet clinical need. \nWhether your group is targeting microsatellite instable (MSI) and stable (MSS) CRC\, a rare GI malignancy or treatment-resistant HCC\, this unique forum is your opportunity to establish clinical collaborations\, plan new combinatorial studies and assess how a future drug candidate can change the clinical landscape. \nExplore the full conference guide here: https://ter.li/9m9m8u \n**A “drug developer” or “researcher” must have a pipeline candidate and/or work for an academic institution\, and must not provide solutions or services for a fee to any other company. All bookings under the drug developer/researcher category are subject to organizer approval.
URL:https://www.pharmajournalist.com/event/gastrointestinal-cancer-drug-development-summit/
LOCATION:Digital Event | EST
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211103
DTEND;VALUE=DATE:20211105
DTSTAMP:20260515T223747
CREATED:20210813T151459Z
LAST-MODIFIED:20210813T151459Z
UID:31349-1635897600-1636070399@www.pharmajournalist.com
SUMMARY:2nd Applied Biocatalysis Summit
DESCRIPTION:Understanding the most recent developments in enzyme-catalyzed processes\, computational technologies\, and cutting-edge methodologies in biocatalytic cascade reactions is key to help the API and chemical industries apply biocatalysis more effectively. \nSpecifically designed alongside experts in the field\, this conference will delve into the key technology\, enzyme design\, manufacturing\, and scale-up challenges that must be overcome to achieve the commercial promise of biocatalysis. \nJoin us online for 2 days of insightful content\, live Q&As\, and 2+ hours of networking\, as we bring together medication developers\, chemical manufacturers\, agriculturists\, and researchers working on the complex and difficult development of biocatalyst technology. \nThis is your comprehensive virtual guide to defining your commercial potential of implementing biocatalysis methods in 2021. \nTo know more visit: https://ter.li/s09i3k
URL:https://www.pharmajournalist.com/event/2nd-applied-biocatalysis-summit/
LOCATION:Digital Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR